Survival Prediction on TCGA-LIHC (test)
0.654C-indexPathMoG
Evaluation results
| Method | Links | |||||
|---|---|---|---|---|---|---|
| PathMoGSample Size (N)=371, Evaluation Protocol=5-fold cross-validation2026.04 | 0.654 | 0.666 | — | — | — | |
| FGCNSample Size (N)=371, Evaluation Protocol=5-fold cross-validation2026.04 | 0.652 | 0.58 | — | — | — | |
| PathGSample Size (N)=371, Evaluation Protocol=5-fold cross-validation2026.04 | 0.647 | 0.653 | — | — | — | |
| RSFSample Size (N)=371, Evaluation Protocol=5-fold cross-validation2026.04 | 0.642 | 0.615 | — | — | — | |
| PCLSample Size (N)=371, Evaluation Protocol=5-fold cross-validation2026.04 | 0.64 | 0.65 | — | — | — | |
| CoxSample Size (N)=371, Evaluation Protocol=5-fold cross-validation2026.04 | 0.626 | 0.598 | — | — | — | |
| CAMRSample Size (N)=371, Evaluation Protocol=5-fold cross-validation2026.04 | 0.625 | 0.661 | — | — | — | |
| GraphSSample Size (N)=371, Evaluation Protocol=5-fold cross-validation2026.04 | 0.597 | 0.638 | — | — | — | |
| HFBSample Size (N)=371, Evaluation Protocol=5-fold cross-validation2026.04 | 0.524 | 0.563 | — | — | — | |
| BioFact-MoECategory=Ours2026.05 | — | — | 75.33 | 75.85 | 73.96 | |
| BiomedCLIPCategory=Vision-language2026.05 | — | — | 65.71 | 67.97 | 66.91 | |
| Entity AlignmentCategory=Vision-language2026.05 | — | — | 74.27 | 72.05 | 70.26 | |
| GLoRIACategory=Vision-language2026.05 | — | — | 73.2 | 72.13 | 70 | |
| Image+Report FusionCategory=Multimodal survival2026.05 | — | — | 64.69 | 65.68 | 64.19 | |
| ResNet-CoxCategory=Image-only2026.05 | — | — | 62.74 | 64.28 | 63.26 | |
| SparseMoECategory=MoE2026.05 | — | — | 72.56 | 73.31 | 71.58 |